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Background: KBG syndrome, a rare autosomal disorder characterised by distinctive craniofacial and skeletal features
and developmental delay, is caused by haploinsufficiency of the ANKRD11 gene.
Results: Here we describe two siblings with multiple symptoms characteristic of KBG and their mother with a milder
phenotype. In the siblings, array-based comparative genomic hybridization (array CGH) identified an intragenic
microduplication affecting ANKRD11 that was absent from the parents’ array CGH profiles. Microsatellite analysis revealed
the maternal origin of the rearrangement and interphase fluorescent in situ hybridization (i-FISH) experiments identified
the rearrangement in low-level mosaicism in the mother. Molecular characterisation of the duplication allele
demonstrated the presence of two mutant ANKRD11 transcripts containing a premature stop codon and predicting a
truncated non-functional protein.
Conclusions: Similarly to deletions and point mutations, this novel pathogenetic rearrangement causes
haploinsufficiency of ANKRD11, resulting in KBG syndrome.
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KBG syndrome (OMIM 148050) is a rare genetic disorder
characterised by distinctive craniofacial features, including
oval/triangular face, brachycephaly, hypertelorism, bulbous
nasal tip, elongated philtrum, wide and arched eyebrows,
macrodontia of the upper central incisors of perman-
ent teeth, skeletal anomalies, hand anomalies, and short
stature. Neurological involvement with developmental
delay, seizures, and intellectual disability is also observed
in affected individuals [1-5]. Since 1975, more than 70
KBG patients have been described [1-16]; among them, a
few familial cases have been reported [9,14,15]. This num-
ber likely reflects an underestimate, because many features
of KBG syndrome have mild clinical presentation, includ-
ing intellectual disability, and none is prerequisite for
the diagnosis [5]. However, based on the review of
most reported patients, it has been suggested that at* Correspondence: finelli@auxologico.it
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unless otherwise stated.least four out of eight major criteria, namely macrodon-
tia, typical gestalt, neurological anomalies, delayed bone
age, costovertebral and/or hand anomalies, short stature,
and the presence of an affected first degree relative, should
be present for the diagnosis [4].
KBG syndrome is caused by haploinsufficiency of the
16q24.3 ANKRD11 gene resulting from either heterozygous
point mutations [5,12,14-16] or chromosomal microdele-
tions [6-11,15]. Five patients with deletions encompassing
solely the ANKRD11 gene [6-8], and ten patients with
larger deletions including several flanking genes have been
described [9,10,14,15]. The ANKRD11 gene encodes the
ankyrin repeat domain-containing protein 11, which is a
member of the family of ankyrin repeat domain-containing
cofactors that are inhibitors of ligand-dependent transcrip-
tional activation [17]. ANKRD11 has two domains that
appear to function in transcriptional repression and one
domain that functions in promoting transcription [17].
Recently it has been shown that the abundance of the
wild- type ANKRD11 is tightly regulated during the cell
cycle; moreover the N-terminus forms homodimers and the
ANKRD11 C-terminus is required for protein degradation
[16]. All reported mutations described in KBG patientsThis is an Open Access article distributed under the terms of the Creative
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sion [5,16] and most of them are predicted to lead to pre-
mature termination codons, possibly resulting in ANKRD11
haploinsufficiency [5]. A phenotypic variability among KBG
patients has been observed, even if the clinical presentation
of mutated and deleted patients is similar, and intra-
and interfamilial variation has been observed in both
patient groups [15].
Here, we describe a new case of KBG vertical
transmission, including two siblings exhibiting typical
phenotypes and carrying an ANKRD11 intragenic duplica-
tion, present in low-level mosaicism in their mildly
affected mother. This intragenic microduplication, the
first rearrangement of its kind reported in this gene,
triggers haploinsufficiency of ANKRD11, resulting in
KBG syndrome and confirming haploinsufficiency as the
pathogenetic mechanism underlying this syndrome.
Case presentation
Clinical report
The probands are the only children of non-consanguineous
Caucasian parents with an unremarkable family history.
The boy was born at term by caesarean section after a preg-
nancy complicated by intrauterine growth restriction
(IUGR). Birth parameters: weight, 2,270 g (−2.9 SD); length,
44 cm (−3.5 SD); occipito-frontal circumference (OFC)
31 cm (−3.1 SD); Apgar scores, 9–9. The girl was born at
term by caesarean section after an uncomplicated preg-
nancy. Birth parameters: weight, 2,730 g (−1.8 SD); length
45.5 cm (−2.6 SD); OFC, 35 cm (+0.5 SD); Apgar scores,
9–9. Birth parameter were calculated according to the
Italian Neonatal Study (INeS) charts [18]. Both siblings were
diagnosed with a congenital atrioventricular canal defect,
which was surgically corrected around the age of 2 years.
The probands were referred to our centre at the ages of
17 (boy) and 13 (girl) (Figure 1). All growth parameters
were below -2 SD [18]. Clinical examination revealed
facial dysmorphisms (Figure 1), including long triangular
face, frontal bossing, arched and bushy eyebrows (with
slight synophrys in the boy), large and prominent ears,
broad and high nasal bridge with bulbous nasal tip, ante-
verted nares, long philtrum, macrodontia of central incisors
(Figure 1f and 1n), and a nasal voice. Skeletal anomalies
included brachymetacarpia (Figure 1c and 1i). Both patients
exhibited moderate intellectual disability. The boy also
exhibited third-degree vesicoureteral reflux, and the girl
had left ureterocele associated with duplex pelvicalyceal
district. The mother exhibited mild facial dysmorphisms,
similar to those of her children, and a nasal voice.
Methods
Array CGH was performed using the Human Genome
CGH Microarray Kit 244 K (Agilent Technologies, Palo
Alto, CA). For microsatellite analysis, polymorphic lociwithin 16q24.3 were selected using the UCSC Genome
Browser (https://genome.ucsc.edu/), and assays were per-
formed using the AmpliTaqGold kit (Life Technologies,
Carlsbad, CA) on an ABI PRISM 310 Genetic Analyzer
(Applied Biosystems, Foster City, CA) with a GS ROX500
size standard (Applied Biosystems), separated by POP4,
and analysed using GeneScan.
i-FISH analysis was performed on peripheral blood
lymphocytes as previously described [19]. The BAC probe
CTD-3200N1 (Invitrogen Ltd., Paisley, UK), which maps
at 16q24.3, was nick-translation labelled with Cy3-dUTP
(Amersham, Chalfont St. Giles, UK). i-FISH false-positive
rate was determined on a healthy subject.
For quantitative gene-expression analysis, total RNA
was collected using Tempus Blood RNA tubes (Applied
Biosystems), isolated using the Tempus Spin RNA Isolation
kit (Applied Biosystems), and reverse-transcribed using the
High-Capacity cDNA Reverse Transcription kit (Applied
Biosystems). Quantitative real-time RT-PCR was performed
using an ABI PRISM 7700 Sequence Detection System
(Applied Biosystems). Levels of ANKRD11 mRNA
were calculated using the 2-ΔΔCt method, normal-
ized against GAPDH (TaqMan ID#: Hs00946576_m1,
ANKRD11 exons 3–4; Hs00946580_m1, ANKRD11
exons 7–8; Hs00946585_gH, ANKRD11 exons 12–13;
Hs99999905_m1, GAPDH; Applied Biosystems). Statistical
analysis was performed by two-tailed Student’s t test;
p < 0.01 was interpreted as significant.
PCR was performed on cDNA using the AmpliTaq
Gold® kit (Applied Biosystems) with transcript-specific
primers for ANKRD11 (forward primer: 5′TGGTGAACC
TCCTGTTAGGC3′; reverse primer: 5′GAAGCTCTTCC
TGCTGTGGT3′; product size: 162 bp, Ta: 59.3°C).
Amplicons were sequenced using the Big Dye® Terminator
v.3.1 Cycle Sequencing kit (Applied Biosystems).
Duplication junction sequences were aligned to the
human reference genome sequence (human genome
assembly GRCh37/hg19), analysed with the ChromasPro
1.5 software (Technelysium Pty Ltd., Tewantin QLD,
Australia), and submitted to GenBank (http://www.ncbi.
nlm.nih.gov/WebSub).
Results
Array CGH revealed that both siblings were heterozy-
gous for a novel microduplication of 89 kb in 16q24.3
(chr16:89,350,931–89,439,639, hg19), so far unreported in
the Database of Genomic Variants (DGV, http://projects.
tcag.ca/variation/project.html) (Figure 2a). The duplication
extends from ANKRD11 intron 2 to exon 9 or intron
10, depending on the minimum and maximum size of
the duplication inferred from reference transcript
NM_013275.5 (Figure 2b). Thus, the proximal breakpoint
occurred between oligonucleotides A_16_P03198579 and
A_14_P119531, and the distal breakpoint between
Figure 1 Facial, dental, and hand profiles of male and female probands. Frontal (a, d) and lateral (b, e) views of the male proband at 17
(a, b) and 22 (d, e) years of age. Frontal (g, l) and lateral (h, m) views of the female proband at 13 (g, h) and 18 (l, m) years of age. Facial
features comprise a long triangular face, frontal bossing, broad and high nasal bridge with bulbous nasal tip, large ears, macrodontia of central
incisors (f, n), retrognathia, and a pointed chin. (c, i) Small and short hands were identified in both sibs.
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(Figure 2b). Parental molecular karyotypes were normal
(Figure 2a).
Microsatellite polymorphisms at informative loci
M1 (chr16:89,391,878-89,391,903, hg19) and M2
(chr16:89,396,404-89,396,438, hg19) revealed the maternal
origin of the duplicated allele. Ratios of peak areas
for individual alleles showed that both siblings inherited
two copies of the maternal allele and one copy of the
paternal allele (Additional file 1: Figure S1).
The mother’s attenuated phenotype and microsatellite
typing suggested low-degree maternal mosaicism of theduplication; this suspicion was confirmed by i-FISH with
BAC probe CTD-3200N1, which partially covers the dupli-
cation (Figure 2b). FISH validated the microarray finding,
confirming an ANKRD11 intragenic tandem duplication in
both siblings (Figure 2c). Scoring of 500 nuclei in
both parents and a normal control revealed that ~5% of
maternal cells carried the duplication (Figure 2d); the
father exhibited no mosaicism (data not shown).
To investigate the pathogenetic effect of the duplication,
we quantitated expression of the ANKRD11 transcript.
For exon junctions 3–4 and 7–8, included in the
duplicated region, PCR product levels were elevated in
Figure 2 ANKRD11 intragenic duplication in the probands and their mother. (a) High-resolution array CGH profiles reveal in both sibs a
duplication affecting part of the ANKRD11 coding region. Both parents’ profiles are normal. (b) Physical map of 16q24.3 showing the exon/intron
structure of ANKRD11 (dark blue), the BAC probe CTD-3200N1 used in i-FISH (red), the deleted region (blue), and its hypothetical maximum size
(dotted line). (c, d) i-FISH of peripheral blood lymphocytes from patient 1 (c) and his mother (d). BAC probe CTD-3200N1 yields two hybridization
signals, one of which is enlarged, in all nuclei of patient 1 (c) and in 5% of maternal nuclei (d) (red arrow).
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duplication, PCR product levels were comparable in pro-
bands and controls (Figure 3a). Consistent with this, direct
sequencing of ANKRD11 cDNA, using primers at the end
of exon 8 and the beginning of exon 3, revealed two
mutant ANKRD11 transcripts (Figure 3b). The duplicationproduces a splice site and so two splice variants were
present, one with exon 8 sequence followed by the dupli-
cated exon 3, and the other with deletion of the first codon
of the duplicated exon 3 (CAG) (Figure 3b). In both
variants, juxtaposition of exon 3 with exon 8 caused a
frameshift resulting in premature termination (Figure 3b).
Figure 3 Molecular characterization of the ANKRD11 intragenic duplication. (a) Relative expression of ANKRD11 mRNA in lymphocytes of
the patients’ mother (pink), male patient (blue), and female patient (lilac), compared to a pool of 10 normal controls (gray), whose value was set
to 1, using Taqman probes for exon junctions 2–3, 7–8, and 12–13. *, p < 0.01. (b) Graphic representation of wild-type and mutated ANKRD11
mRNAs and corresponding proteins. Non-coding exons are in pink, and coding exons in light pink. Gray arrows show the duplication of exons
3–8, oriented in tandem. Black arrows indicate positions of primers used to sequence the duplication junction. The electropherogram of the
mutant ANKRD11 transcript is shown, with exon 8 in yellow and exon 3 in blue; the amino-acid sequence is above the nucleotide sequence.
Juxtaposition of exon 3 with exon 8 creates a premature termination codon. GenBank accession numbers of the splice-variant transcripts are
KM670019 and KM670020. The truncated protein translated from the mutant ANKRD11 transcript is shown at bottom.
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the ankyrin repeats (Figure 3b).
Discussion
To date, only point mutations and chromosomal deletions
of ANKRD11 have been reported in patients with KBG
syndrome [5-11,13-15]. Here, we describe the first reported
case of KBG syndrome with intragenic microduplication ofANKRD11. The tandemly duplicated segment extends
from intron 2 to exon 9. cDNA sequencing showed the
presence of two mutant transcripts, suggesting that the
mutant allele is not subject to nonsense-mediated RNA
decay. The stability of the mutant transcripts has previ-
ously been observed [16]. The rearrangement of our sib-
lings gives rise to a splice site, generating two transcripts,
where a frameshift creates a stop codon after exon 8. The
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ankyrin repeats (N-terminus) and lack all transcrip-
tional regulatory domains (C-terminus). Notably, point
mutations of ANKRD11 associated with KBG syndrome
map to exon 9 or IVS10 and produce similarly truncated
proteins [5,16].
Interestingly the rearrangement is present in low-level
mosaicism in the probands’ mother, thus documenting a
further case of vertical transmission of KBG syndrome
[9,14,15]. Parental low level somatic mosaicism is emerging
as a frequent mechanism of recurrence as elucidated in
recent studies by the increasing sensitivity of genomic
technologies with important implications in recurrence
risk for couples with children affected by genomic disor-
ders [20]. Consistent with the presence of the microdupli-
cation in only 5% of peripheral blood cells, the mother
exhibits very mild KBG phenotypes, characterised only by
facial dysmorphisms and nasal voice. Thus, as previously
postulated [9,16], the phenotypic effect of mosaic ANKRD11
haploinsufficiency might be dose-dependent.
In addition to typical symptoms of KBG syndrome, both
sibling presented with congenital atrioventricular canal
defects, a minor feature of KBG syndrome [2,13,15,21].
Our patients also presented with kidney abnormalities not
previously reported in KBG patients; to date is difficult to
assess if they represent just an association or a further
delineation of the known KBG syndrome phenotype.
Conclusions
Our study discloses a novel pathogenetic rearrangement
that triggers ANKRD11 haploinsufficiency, the same
mechanism by which deletions and point mutations cause
KBG syndrome. These observations further confirm that
ANKRD11 haploinsufficiency is the cause of KBG syn-
drome. Molecular evidences demonstrated the pathogen-
etic effect of the chromosomal duplication identified by
array CGH, and led to FISH identification in the mother
of the chromosomal aberration overlooked by array CGH
due to the low mosaicism level.
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